Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person The ubiquitin (Ub)-dependent and Ub-independent proteasomal ...

Class:IdSummation:9912701
_displayNameThe ubiquitin (Ub)-dependent and Ub-independent proteasomal ...
_timestamp2024-06-17 18:11:07
created[InstanceEdit:9912683] Shamovsky, Veronica, 2024-06-10
literatureReference[LiteratureReference:9912644] The immunoproteasome and viral infection: a complex regulator of inflammation
[LiteratureReference:9912712] IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response
[LiteratureReference:9912696] New Insights into the Function of the Immunoproteasome in Immune and Nonimmune Cells
[LiteratureReference:9912667] Proteasome composition in immune cells implies special immune‐cell‐specific immunoproteasome function
[LiteratureReference:9912704] Quantitative measurement of the requirement of diverse protein degradation pathways in MHC class I peptide presentation
[LiteratureReference:9912620] The biogenesis of the immunopeptidome
[LiteratureReference:9912651] Driving forces of proteasome-catalyzed peptide splicing in yeast and humans
[LiteratureReference:9912729] Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopes
[LiteratureReference:9912705] Protein degradation by human 20S proteasomes elucidates the interplay between peptide hydrolysis and splicing
[LiteratureReference:9912698] Current Concepts of Antigen Cross-Presentation
[LiteratureReference:9912648] Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome
[LiteratureReference:9908705] Structural insights into the human PA28-20S proteasome enabled by efficient tagging and purification of endogenous proteins
[LiteratureReference:9908278] Visualizing chaperone-mediated multistep assembly of the human 20S proteasome
[LiteratureReference:9912679] The Molecular Mechanisms Governing the Assembly of the Immuno- and Thymoproteasomes in the Presence of Constitutive Proteasomes
[LiteratureReference:9912723] Interferon-γ-induced upregulation of immunoproteasome subunit assembly overcomes bortezomib resistance in human hematological cell lines
[LiteratureReference:982999] 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide
[LiteratureReference:982859] Post-proteasomal antigen processing for major histocompatibility complex class I presentation
[LiteratureReference:9912591] Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum
[LiteratureReference:982980] Characterizing the specificity and cooperation of aminopeptidases in the cytosol and endoplasmic reticulum during MHC class I antigen presentation
[LiteratureReference:9912643] Cytosolic aminopeptidases influence MHC class I-mediated antigen presentation in an allele-dependent manner
[LiteratureReference:9908575] Assembly mechanisms of specialized core particles of the proteasome
[LiteratureReference:9908563] Structure of human immunoproteasome with a reversible and noncompetitive inhibitor that selectively inhibits activated lymphocytes
[LiteratureReference:9912664] Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
[LiteratureReference:9908691] Cryo-EM of mammalian PA28αβ-iCP immunoproteasome reveals a distinct mechanism of proteasome activation by PA28αβ
[LiteratureReference:9912715] Conformational maps of human 20S proteasomes reveal PA28- and immuno-dependent inter-ring crosstalks
[LiteratureReference:9907904] Molecular architecture and assembly of the eukaryotic proteasome
[LiteratureReference:9912682] Evaluation of Immunoproteasome-Specific Proteolytic Activity Using Fluorogenic Peptide Substrates
modified[InstanceEdit:9913361] Shamovsky, Veronica, 2024-06-13
[InstanceEdit:9913782] Shamovsky, Veronica, 2024-06-17
textThe ubiquitin (Ub)-dependent and Ub-independent proteasomal degradation is crucial for the turnover of damaged and regulatory proteins within cells. This mechanism also generates antigenic peptides that can be loaded on to class I major histocompatibility complex (MHC I) molecules and presented externally to cytotoxic CD8+ T lymphocytes (CTLs) (Mamrosh JL et al., 2023; reviewed by Embgenbroich M & Burgdorf S 2018; Admon A 2023).

This Reactome event shows Ub-independent antigen processing by immunoproteasome, a specialized form of the proteasome in which the standard catalytic subunits PSMB6 (β1), PSMB7 (β2), and PSMB5 (β5) of 20S core particle (CP) are replaced with PSMB9 (β1i), PSMB10 (β2i), and PSMB8 (β5i), respectively (Shin EC et al., 2006; Bai M et al., 2014; Santos R et al., 2017). This variation of the core particle is known as 20S iCP. Immunoproteasomes utilize the PA28 regulatory particle, a heteroheptamer of 4xPSME1:3xPSME2, to degrade substrates (Lesne J et al., 2020; Chen J et al., 2021). The catalytic and regulatory subunits of immunoproteasomes are constitutively expressed in various immune cells, such as T cells, B cells, and antigen-presenting cells (Inholz K et al., 2024; reviewed by McCarthy MK & Weinberg JB 2015). Their expression is also induced by pro-inflammatory cytokines such as interferon-gamma (IFNγ), type I interferons, and tumor necrosis factor alpha (TNF-α) in infected cells (Heink S et al. 2005; Niewerth D et al., 2014; reviewed by Kimura H et al. 2015; McCarthy MK & Weinberg JB 2015). While both standard catalytic β subunits of 20S CP and their immunoproteasome counterparts of 20S iCP exhibit caspase-like, trypsin-like, and chymotrypsin-like proteolytic activities, immunoproteasomes possess enhanced chymotrypsin- and trypsin-like activities, alongside with the reduced caspase-like activity (Cascio P et al., 2001; Kim S et al., 2022). These distinct enzymatic properties of immunoproteasomes generate C-terminal cleavage patterns that enhance loading of peptides onto MHC class I for immune presentation to killer T cells (reviewed in Tomko and Hochstrasser 2013). The peptides generated by the proteasome are either of the ideal length for binding to MHC class I molecules, ranging from 8 to 9 amino acids, or can be further cleaved by cytoplasmic aminopeptidases, including leucine aminopeptidase, puromycin-sensitive aminopeptidase, bleomycin hydrolase, and tripeptidyl peptidase II (Hearn A et al., 2010; Kim E et al., 2010). Within the endoplasmic reticulum (ER), extended peptides can be further trimmed by ER-resident aminopeptidases (ERAP1 and ERAP2) before being loaded onto MHC class I molecules (Rock KL et al., 2004; Saveanu L et al., 2005; Hearn A et al., 2010).

(summation)[BlackBoxEvent:9912655] Proteasomal cleavage of intracellular substrate (immunoproteasome catalyst) [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by The ubiquitin (Ub)-dependent and Ub-independent proteasomal ... (9912701)